Can surgery enhance survival rates in metastatic breast cancer?
Written By : Isra Zaman
Medically Reviewed By : Dr. Kamal Kant Kohli
Published On 2023-10-10 03:45 GMT | Update On 2023-10-10 03:45 GMT
Advertisement
A recent review published in The Oncologist showed that surgery of the primary breast tumor in patients with de novo metastatic breast cancer does not significantly prolong overall survival, except for potential benefits in younger/premenopausal individuals, highlighting the need for further clinical trials to guide decision-making.
The research team meticulously analyzed data from multiple sources, including the Cochrane Library, Embase, Medline (OVID), and Web of Science, with the latest update in July 2023. They also manually searched conference proceedings for relevant information.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.